FindMyRecallSubscribe
Class I: serious health riskTerminated

Azurity Pharmaceuticals Firvanq Recall

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit…

Azurity Pharmaceuticals, Inc. · Wilmington, MA

Risk level
Class I
Reported by FDA
Oct 13, 2021
Recall ID
D-0003-2022
Check your lot numberHow we source this data

Summary

Azurity Pharmaceuticals recalled Firvanq starting Aug 24, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0003-2022 on Oct 13, 2021. Reason: Product Mix-up: Incorrect diluent component included in the kit. Status: Terminated.

Why it was recalled

Product Mix-up: Incorrect diluent component included in the kit.

Product description

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.

Lot numbers, UPCs & expiration codes

Lot # 21035, Exp 7/31/2022

Where it was sold

USA nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0003-2022
Classification
Class I
Status
Terminated
Recall initiated
Aug 24, 2021
FDA report date
Oct 13, 2021
Quantity
2,751 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Azurity Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0003-2022, exactly as published.

Show all FDA fields
City
Wilmington
State
MA
Status
Terminated
Country
United States
Event ID
88547
Address
841 Woburn St
Code information
Lot # 21035, Exp 7/31/2022
Postal code
01887-3414
Report date
Oct 13, 2021
Product type
Drugs
Recall number
D-0003-2022
Classification
Class I
Recalling firm
Azurity Pharmaceuticals, Inc.
Product quantity
2,751 kits
Termination date
May 12, 2022
Reason for recall
Product Mix-up: Incorrect diluent component included in the kit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.
Distribution pattern
USA nationwide
Recall initiation date
Aug 24, 2021
Initial firm notification
Letter
Center classification date
Oct 5, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0003-2022, published Oct 13, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls